The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, involves a complex several-stage synthetic process. Early routes focused on protein section coupling, utilizing solid-phase creation methodologies to build the long amino acid sequence. Subsequent investigation has explored different approaches, including… Read More